A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults

Name: A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults
Published: 2021
License: Public Domain

ViiV Healthcare · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

hiv hiv-infections

hiv infections, antiretroviral-naïve, broadly neutralizing antibody, gsk3810109a, hiv, n6ls, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study to Evaluate the Antiviral Effect, Safety and Tolerability of GSK3810109A in Viremic Human Immunodeficiency Virus (HIV)-1 Infected Adults

Related documents